SILEXION THERAPEUTICS CORP Payments for Repurchase of Warrants
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- SILEXION THERAPEUTICS CORP payments for repurchase of warrants for the quarter ending 2026-06-30 was $125.00K, a 25.00% increase year-over-year.
- SILEXION THERAPEUTICS CORP payments for repurchase of warrants for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP payments for repurchase of warrants for the quarter ending 2025-12-31 was $46.00K.
- SILEXION THERAPEUTICS CORP payments for repurchase of warrants for the quarter ending 2025-09-30 was $232.00K.
| Period end | Payments for Repurchase of Warrants 3 month | Payments for Repurchase of Warrants 12 month |
|---|---|---|
| 2026-06-30 | $125.00K 10-Q · filed 2026-08-14 | $403.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 S-1/A · filed 2026-08-10 | $378.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $46.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $740.00K S-1/A · filed 2026-08-10 |
| 2025-09-30 | $232.00K 10-Q · filed 2025-11-12 | $694.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-14 | $462.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $362.00K S-1/A · filed 2026-08-10 | $362.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | $0.00 S-1/A · filed 2026-08-10 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |